Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The macular xanthophylls.

Shazia S Ahmed1, McGregor N Lott, Dennis M Marcus

  • 1Department of Ophthalmology, Medical College of Georgia, Augusta, Georgia 30912-3400, USA.

Survey of Ophthalmology
|March 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Aflibercept Dosing Frequency on Retinal Nonperfusion Progression Assessed by Ultra-Widefield Angiography After Endolaserless Vitrectomy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.

Journal of vitreoretinal diseases·2026
Same author

Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III INSIGHT randomized clinical trial.

Expert opinion on biological therapy·2026
Same author

Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN).

Ophthalmology science·2026
Same author

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial.

JAMA ophthalmology·2025
Same author

Clinical Performance of Semi-Automated Spectral-Domain Optical Coherence Tomography Angiography.

Journal of clinical medicine·2024
Same author

Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA.

Ophthalmology. Retina·2024
Same journal

Trends in pediatric uveitis: A systematic review and meta-epidemiological investigation of geographic, economic, and climate factors.

Survey of ophthalmology·2026
Same journal

Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis.

Survey of ophthalmology·2026
Same journal

Macular telangiectasia masqueraders.

Survey of ophthalmology·2026
Same journal

Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.

Survey of ophthalmology·2026
Same journal

Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies.

Survey of ophthalmology·2026
Same journal

Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.

Survey of ophthalmology·2026
See all related articles

Macular pigments like lutein and zeaxanthin protect the macula and may reduce the risk of age-related macular degeneration. Supplementation can increase these pigment levels, but effects on vision require further study.

Area of Science:

  • Ophthalmology
  • Nutritional Science
  • Carotenoid Research

Background:

  • Macular pigments, primarily lutein, zeaxanthin, and meso-zeaxanthin, are crucial for retinal health.
  • These carotenoids possess antioxidant and light-filtering properties, protecting the macula from oxidative stress and high-energy light.
  • Age-related macular degeneration (AMD) is a leading cause of vision loss, and macular pigment density is linked to its risk.

Purpose of the Study:

  • To explore the properties, uptake, and distribution of macular pigments.
  • To elaborate on the protective roles of macular pigments against AMD.
  • To review the efficacy of oral lutein and zeaxanthin supplementation and discuss methods for assessing macular pigment density.

Main Methods:

  • Literature review on carotenoid properties and ocular health.

Related Experiment Videos

  • Analysis of studies investigating oral supplementation with lutein and zeaxanthin.
  • Discussion of standardized methods for macular pigment density assessment.

    • Main Results:

    • Increased macular pigment levels correlate with a reduced risk of AMD.
    • Oral supplementation with lutein and zeaxanthin has been shown to increase macular pigment and plasma levels.
    • The direct impact of supplementation on ocular function remains to be fully elucidated.

    Conclusions:

    • Macular pigments play a vital protective role in the macula, particularly concerning AMD.
    • Oral supplementation is a viable strategy to increase macular pigment density.
    • Further research is needed to fully understand the functional benefits of supplementation and to refine assessment methods for macular xanthophylls in AMD.